open access

Vol 65, No 3 (2014)
Original papers
Published online: 2014-06-27
Submitted: 2014-06-27
Accepted: 2014-06-27
Get Citation

The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes

Mariusz Kuźmicki, Beata Telejko, Danuta Lipińska, Justyna Pliszka, Juliusz Wilk, Natalia Wawrusiewicz-Kurylonek, Anna Zielińska, Angelika Sobota, Adam Krętowski, Maria Górska, Jacek Szamatowicz
DOI: 10.5603/EP.2014.0023
·
Endokrynologia Polska 2014;65(3):169-175.

open access

Vol 65, No 3 (2014)
Original papers
Published online: 2014-06-27
Submitted: 2014-06-27
Accepted: 2014-06-27

Abstract

Introduction: Interleukin-6 (IL-6) is a pleiotropic cytokine which signals through a cell surface receptor complex consisting of a cognatereceptor subunit (IL-6R) and glycoprotein 130 (gp130), which is considered an antagonist to the IL-6R/IL-6 pathway. The aim of the present study was to assess IL-6/IL-6R/gp130 system and Th17 associated cytokines in different time points during and after pregnancy in women with gestational diabetes mellitus (GDM) and normal glucose tolerance (NGT).

Material and methods: Serum levels of IL-6, sIL6R, sgp130, IL-17 and IL-23 were measured in 91 women divided into three groups: GDMin the 24th–28th week of gestation (visit 1), NGT at the 1st visit and GDM in the 29th-32nd week, and NGT at both visits.

Results: The patients with GDM recognised at the 1st visit had significantly higher IL-6 (p = 0.02) and sgp130 (p = 0.03) concentrations than had the women with NGT, whereas the women with GDM diagnosed at the 2nd visit had elevated sIL-6R concentrations (p = 0.03). The patients with low sIL-6R but high sgp130 concentration had significantly higher glucose levels (p = 0.04) and lower IL-6 values (p = 0.04) than had the patients with low sIL-6R and sgp130 concentrations. IL-17 and IL-23 were detected in approximately one-third of the population studied. A trend towards higher IL-17 levels was observed in the subjects with GDM, but the differences were not significant.

Conclusions: Our results suggest that an increased serum sgp130 concentration in the patients with GDM might represent a compensatory mechanism, controlling intracellular IL-6 signalling and preventing the activation of the IL-6/IL-6R pathway.

Abstract

Introduction: Interleukin-6 (IL-6) is a pleiotropic cytokine which signals through a cell surface receptor complex consisting of a cognatereceptor subunit (IL-6R) and glycoprotein 130 (gp130), which is considered an antagonist to the IL-6R/IL-6 pathway. The aim of the present study was to assess IL-6/IL-6R/gp130 system and Th17 associated cytokines in different time points during and after pregnancy in women with gestational diabetes mellitus (GDM) and normal glucose tolerance (NGT).

Material and methods: Serum levels of IL-6, sIL6R, sgp130, IL-17 and IL-23 were measured in 91 women divided into three groups: GDMin the 24th–28th week of gestation (visit 1), NGT at the 1st visit and GDM in the 29th-32nd week, and NGT at both visits.

Results: The patients with GDM recognised at the 1st visit had significantly higher IL-6 (p = 0.02) and sgp130 (p = 0.03) concentrations than had the women with NGT, whereas the women with GDM diagnosed at the 2nd visit had elevated sIL-6R concentrations (p = 0.03). The patients with low sIL-6R but high sgp130 concentration had significantly higher glucose levels (p = 0.04) and lower IL-6 values (p = 0.04) than had the patients with low sIL-6R and sgp130 concentrations. IL-17 and IL-23 were detected in approximately one-third of the population studied. A trend towards higher IL-17 levels was observed in the subjects with GDM, but the differences were not significant.

Conclusions: Our results suggest that an increased serum sgp130 concentration in the patients with GDM might represent a compensatory mechanism, controlling intracellular IL-6 signalling and preventing the activation of the IL-6/IL-6R pathway.

Get Citation

Keywords

IL-6; IL-6R; gp130; IL-17; IL-23; gestational diabetes

About this article
Title

The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes

Journal

Endokrynologia Polska

Issue

Vol 65, No 3 (2014)

Pages

169-175

Published online

2014-06-27

DOI

10.5603/EP.2014.0023

Bibliographic record

Endokrynologia Polska 2014;65(3):169-175.

Keywords

IL-6
IL-6R
gp130
IL-17
IL-23
gestational diabetes

Authors

Mariusz Kuźmicki
Beata Telejko
Danuta Lipińska
Justyna Pliszka
Juliusz Wilk
Natalia Wawrusiewicz-Kurylonek
Anna Zielińska
Angelika Sobota
Adam Krętowski
Maria Górska
Jacek Szamatowicz

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl